Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of the endocrine system (HP:0000818)help
Parent Node:
expand
Abnormal circulating hormone concentration (HP:0003117)help
Parent Node:
expand
Puberty and gonadal disorders (HP:0008373)help
..Starting node
..expand
Abnormal circulating estrogen level (HP:0025132)help
Term ID: 25132
Name: Abnormal circulating estrogen level
Synonym: Abnormal circulating oestrogen level; Abnormal estrogen level; Abnormal oestrogen level
Definition: A deviation from normal concentration of the hormone estrogen in the blood circulation.
Comments:
Reference: HP:0025132
Genes and Diseases:
 
       Child Nodes:
........expandAbnormal serum estradiol (HP:0025133) help
................... HP:0008214 Decreased serum estradiol
................... HP:0025134 Increased serum estradiol
........expandAbnormal serum estriol (HP:0025135) help
................... HP:0025136 Increased serum estriol
................... HP:0025137 Decreased serum estriol
........expandAbnormal serum estrone (HP:0025138) help
................... HP:0025139 Increased serum estrone
................... HP:0025140 Decreased serum estrone

 Sister Nodes: 
..expandAbnormal circulating progesterone level (HP:0031212) help
..expandAbnormal circulating testosterone concentration (HP:0030087) help
..expandAbsence of pubertal development (HP:0008197) help
..expandAbsence of secondary sex characteristics (HP:0008187) help
..expandAdrenogenital syndrome (HP:0000840) help
..expandAndrogen insufficiency (HP:0008226) help
..expandDelayed puberty (HP:0000823) help
..expandEarly onset of sexual maturation (HP:0100000) help
..expandHypogonadism (HP:0000135) help
..expandIrregular menstruation (HP:0000858) help
..expandLeydig cell insensitivity to gonadotropin (HP:0002929) help
..expandPrimary gonadal insufficiency (HP:0008193) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0025132HP:0025132Abnormal circulating estrogen level0AKT1 CL E G H207391ORPHA:2495Meningioma54
HP:0025132HP:0025132Abnormal circulating estrogen level0AR CL E G H367644ORPHA:99429Complete androgen insensitivity syndrome125
HP:0025132HP:0025132Abnormal circulating estrogen level0AR CL E G H367644ORPHA:90797Partial androgen insensitivity syndromeHP:0040282 - Frequent125
HP:0025132HP:0025132Abnormal circulating estrogen level0BAP1 CL E G H8314950ORPHA:2495Meningioma184
HP:0025132HP:0025132Abnormal circulating estrogen level0BMP15 CL E G H92101068ORPHA:24346,XX gonadal dysgenesis16
HP:0025132HP:0025132Abnormal circulating estrogen level0BNC1 CL E G H6461081ORPHA:24346,XX gonadal dysgenesis
HP:0025132HP:0025132Abnormal circulating estrogen level0BNC1 CL E G H6461081OMIM:618723PREMATURE OVARIAN FAILURE 16; POF16
HP:0025132HP:0025132Abnormal circulating estrogen level0CDKN2A CL E G H10291787ORPHA:1501Adrenocortical carcinoma289
HP:0025132HP:0025132Abnormal circulating estrogen level0CTDP1 CL E G H91502498OMIM:604168Congenital cataracts, facial dysmorphism, and neuropathy17
HP:0025132HP:0025132Abnormal circulating estrogen level0CTNNB1 CL E G H14992514ORPHA:1501Adrenocortical carcinoma88
HP:0025132HP:0025132Abnormal circulating estrogen level0CYB5A CL E G H15282570ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiency2
HP:0025132HP:0025132Abnormal circulating estrogen level0CYP17A1 CL E G H15862593ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiency53
HP:0025132HP:0025132Abnormal circulating estrogen level0DCAF17 CL E G H8006725784ORPHA:3464Woodhouse-Sakati syndrome87
HP:0025132HP:0025132Abnormal circulating estrogen level0DHH CL E G H508462865ORPHA:16856346,XY gonadal dysgenesis-motor and sensory neuropathy syndrome21
HP:0025132HP:0025132Abnormal circulating estrogen level0DHX37 CL E G H5764717210ORPHA:25151046,XY partial gonadal dysgenesis2
HP:0025132HP:0025132Abnormal circulating estrogen level0DMRT3 CL E G H5852413909ORPHA:25151046,XY partial gonadal dysgenesis1
HP:0025132HP:0025132Abnormal circulating estrogen level0FOXL2 CL E G H6681092ORPHA:572333Blepharophimosis-ptosis-epicanthus inversus syndrome plus92
HP:0025132HP:0025132Abnormal circulating estrogen level0FSHB CL E G H24883964ORPHA:52901Isolated follicle stimulating hormone deficiency23
HP:0025132HP:0025132Abnormal circulating estrogen level0FSHR CL E G H24923969ORPHA:24346,XX gonadal dysgenesis50
HP:0025132HP:0025132Abnormal circulating estrogen level0GATA4 CL E G H26264173ORPHA:25151046,XY partial gonadal dysgenesis87
HP:0025132HP:0025132Abnormal circulating estrogen level0GNRH1 CL E G H27964419OMIM:614841Hypogonadotropic hypogonadism 12 with or without anosmia15
HP:0025132HP:0025132Abnormal circulating estrogen level0KISS1 CL E G H38146341OMIM:614842Hypogonadotropic hypogonadism 13 with or without anosmia3
HP:0025132HP:0025132Abnormal circulating estrogen level0LARS2 CL E G H2339517095OMIM:615300Perrault syndrome 454
HP:0025132HP:0025132Abnormal circulating estrogen level0LEP CL E G H39526553ORPHA:66628Obesity due to congenital leptin deficiency47
HP:0025132HP:0025132Abnormal circulating estrogen level0LEPR CL E G H39536554ORPHA:179494Obesity due to leptin receptor gene deficiency46
HP:0025132HP:0025132Abnormal circulating estrogen level0MAP3K1 CL E G H42146848ORPHA:25151046,XY partial gonadal dysgenesis13
HP:0025132HP:0025132Abnormal circulating estrogen level0MCM9 CL E G H25439421484OMIM:616185Ovarian dysgenesis 44
HP:0025132HP:0025132Abnormal circulating estrogen level0MRPS22 CL E G H5694514508ORPHA:24346,XX gonadal dysgenesis25
HP:0025132HP:0025132Abnormal circulating estrogen level0NDNF CL E G H7962526256OMIM:618841HYPOGONADOTROPIC HYPOGONADISM 25 WITH ANOSMIA; HH25
HP:0025132HP:0025132Abnormal circulating estrogen level0NF2 CL E G H47717773ORPHA:2495Meningioma220
HP:0025132HP:0025132Abnormal circulating estrogen level0NR0B1 CL E G H1907960ORPHA:25151046,XY partial gonadal dysgenesis48
HP:0025132HP:0025132Abnormal circulating estrogen level0NR5A1 CL E G H25167983ORPHA:24346,XX gonadal dysgenesis38
HP:0025132HP:0025132Abnormal circulating estrogen level0NR5A1 CL E G H25167983ORPHA:25151046,XY partial gonadal dysgenesis38
HP:0025132HP:0025132Abnormal circulating estrogen level0NUP107 CL E G H5712229914ORPHA:24346,XX gonadal dysgenesis5
HP:0025132HP:0025132Abnormal circulating estrogen level0PDGFB CL E G H51558800ORPHA:2495Meningioma9
HP:0025132HP:0025132Abnormal circulating estrogen level0PIK3CA CL E G H52908975ORPHA:2495Meningioma162
HP:0025132HP:0025132Abnormal circulating estrogen level0POLR3A CL E G H1112830074ORPHA:3455Wiedemann-Rautenstrauch syndrome138
HP:0025132HP:0025132Abnormal circulating estrogen level0POLR3H CL E G H17156830349ORPHA:24346,XX gonadal dysgenesis
HP:0025132HP:0025132Abnormal circulating estrogen level0POR CL E G H54479208ORPHA:95699Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency76
HP:0025132HP:0025132Abnormal circulating estrogen level0PRKAR1A CL E G H55739388ORPHA:1501Adrenocortical carcinoma134
HP:0025132HP:0025132Abnormal circulating estrogen level0PSMC3IP CL E G H2989317928ORPHA:24346,XX gonadal dysgenesis2
HP:0025132HP:0025132Abnormal circulating estrogen level0SEMA3A CL E G H1037110723OMIM:614897Hypogonadotropic hypogonadism 16 with or without anosmia14
HP:0025132HP:0025132Abnormal circulating estrogen level0SMARCB1 CL E G H659811103ORPHA:2495Meningioma87
HP:0025132HP:0025132Abnormal circulating estrogen level0SMARCE1 CL E G H660511109ORPHA:2495Meningioma47
HP:0025132HP:0025132Abnormal circulating estrogen level0SMO CL E G H660811119ORPHA:2495Meningioma22
HP:0025132HP:0025132Abnormal circulating estrogen level0SOX9 CL E G H666211204ORPHA:25151046,XY partial gonadal dysgenesis109
HP:0025132HP:0025132Abnormal circulating estrogen level0SPIDR CL E G H2351428971ORPHA:24346,XX gonadal dysgenesis2
HP:0025132HP:0025132Abnormal circulating estrogen level0SPIDR CL E G H2351428971OMIM:619665OVARIAN DYSGENESIS 9; ODG92
HP:0025132HP:0025132Abnormal circulating estrogen level0SRY CL E G H673611311ORPHA:25151046,XY partial gonadal dysgenesis23
HP:0025132HP:0025132Abnormal circulating estrogen level0STAG3 CL E G H1073411356OMIM:615723Premature ovarian failure 84
HP:0025132HP:0025132Abnormal circulating estrogen level0SUFU CL E G H5168416466ORPHA:2495Meningioma124
HP:0025132HP:0025132Abnormal circulating estrogen level0TERT CL E G H701511730ORPHA:1501Adrenocortical carcinoma238
HP:0025132HP:0025132Abnormal circulating estrogen level0TERT CL E G H701511730ORPHA:2495Meningioma238
HP:0025132HP:0025132Abnormal circulating estrogen level0TP53 CL E G H715711998ORPHA:1501Adrenocortical carcinoma911
HP:0025132HP:0025132Abnormal circulating estrogen level0TRAF7 CL E G H8423120456ORPHA:2495Meningioma
HP:0025132HP:0025132Abnormal circulating estrogen level0VAMP7 CL E G H684511486ORPHA:25151046,XY partial gonadal dysgenesis2
HP:0025132HP:0025132Abnormal circulating estrogen level0WT1 CL E G H749012796ORPHA:25151046,XY partial gonadal dysgenesis177
HP:0025132HP:0025132Abnormal circulating estrogen level0WT1 CL E G H749012796ORPHA:347Frasier syndrome177
HP:0025132HP:0025132Abnormal circulating estrogen level0WWOX CL E G H5174112799ORPHA:25151046,XY partial gonadal dysgenesis149
HP:0025132HP:0025132Abnormal circulating estrogen level0XRCC2 CL E G H751612829OMIM:619146PREMATURE OVARIAN FAILURE 17; POF17125
HP:0025132HP:0025132Abnormal circulating estrogen level0ZFPM2 CL E G H2341416700ORPHA:25151046,XY partial gonadal dysgenesis31
HP:0025132HP:0025132Abnormal circulating estrogen level0ZNRF3 CL E G H8413318126ORPHA:1501Adrenocortical carcinoma
HP:0025132HP:0025132Abnormal circulating estrogen level0ZSWIM7 CL E G H12515026993ORPHA:24346,XX gonadal dysgenesis
HP:0025132HP:0025132Abnormal circulating estrogen level0ZSWIM7 CL E G H12515026993OMIM:619834OVARIAN DYSGENESIS 10; ODG10
HP:0025132HP:0025138Abnormal serum estrone1 CL E G H
HP:0025132HP:0025135Abnormal serum estriol1 CL E G H
HP:0025132HP:0025133Abnormal serum estradiol1AKT1 CL E G H207391ORPHA:2495Meningioma54
HP:0025132HP:0025133Abnormal serum estradiol1AR CL E G H367644ORPHA:99429Complete androgen insensitivity syndrome125
HP:0025132HP:0025133Abnormal serum estradiol1AR CL E G H367644ORPHA:90797Partial androgen insensitivity syndrome125
HP:0025132HP:0025133Abnormal serum estradiol1BAP1 CL E G H8314950ORPHA:2495Meningioma184
HP:0025132HP:0025133Abnormal serum estradiol1BMP15 CL E G H92101068ORPHA:24346,XX gonadal dysgenesis16
HP:0025132HP:0025133Abnormal serum estradiol1BNC1 CL E G H6461081ORPHA:24346,XX gonadal dysgenesis
HP:0025132HP:0025133Abnormal serum estradiol1BNC1 CL E G H6461081OMIM:618723PREMATURE OVARIAN FAILURE 16; POF16
HP:0025132HP:0025133Abnormal serum estradiol1CDKN2A CL E G H10291787ORPHA:1501Adrenocortical carcinoma289
HP:0025132HP:0025133Abnormal serum estradiol1CTDP1 CL E G H91502498OMIM:604168Congenital cataracts, facial dysmorphism, and neuropathy17
HP:0025132HP:0025133Abnormal serum estradiol1CTNNB1 CL E G H14992514ORPHA:1501Adrenocortical carcinoma88
HP:0025132HP:0025133Abnormal serum estradiol1CYB5A CL E G H15282570ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiency2
HP:0025132HP:0025133Abnormal serum estradiol1CYP17A1 CL E G H15862593ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiency53
HP:0025132HP:0025133Abnormal serum estradiol1DCAF17 CL E G H8006725784ORPHA:3464Woodhouse-Sakati syndrome87
HP:0025132HP:0025133Abnormal serum estradiol1DHH CL E G H508462865ORPHA:16856346,XY gonadal dysgenesis-motor and sensory neuropathy syndrome21
HP:0025132HP:0025133Abnormal serum estradiol1DHX37 CL E G H5764717210ORPHA:25151046,XY partial gonadal dysgenesis2
HP:0025132HP:0025133Abnormal serum estradiol1DMRT3 CL E G H5852413909ORPHA:25151046,XY partial gonadal dysgenesis1
HP:0025132HP:0025133Abnormal serum estradiol1FOXL2 CL E G H6681092ORPHA:572333Blepharophimosis-ptosis-epicanthus inversus syndrome plus92
HP:0025132HP:0025133Abnormal serum estradiol1FSHB CL E G H24883964ORPHA:52901Isolated follicle stimulating hormone deficiency23
HP:0025132HP:0025133Abnormal serum estradiol1FSHR CL E G H24923969ORPHA:24346,XX gonadal dysgenesis50
HP:0025132HP:0025133Abnormal serum estradiol1GATA4 CL E G H26264173ORPHA:25151046,XY partial gonadal dysgenesis87
HP:0025132HP:0025133Abnormal serum estradiol1GNRH1 CL E G H27964419OMIM:614841Hypogonadotropic hypogonadism 12 with or without anosmia15
HP:0025132HP:0025133Abnormal serum estradiol1KISS1 CL E G H38146341OMIM:614842Hypogonadotropic hypogonadism 13 with or without anosmia3
HP:0025132HP:0025133Abnormal serum estradiol1LARS2 CL E G H2339517095OMIM:615300Perrault syndrome 454
HP:0025132HP:0025133Abnormal serum estradiol1LEP CL E G H39526553ORPHA:66628Obesity due to congenital leptin deficiency47
HP:0025132HP:0025133Abnormal serum estradiol1LEPR CL E G H39536554ORPHA:179494Obesity due to leptin receptor gene deficiency46
HP:0025132HP:0025133Abnormal serum estradiol1MAP3K1 CL E G H42146848ORPHA:25151046,XY partial gonadal dysgenesis13
HP:0025132HP:0025133Abnormal serum estradiol1MCM9 CL E G H25439421484OMIM:616185Ovarian dysgenesis 44
HP:0025132HP:0025133Abnormal serum estradiol1MRPS22 CL E G H5694514508ORPHA:24346,XX gonadal dysgenesis25
HP:0025132HP:0025133Abnormal serum estradiol1NDNF CL E G H7962526256OMIM:618841HYPOGONADOTROPIC HYPOGONADISM 25 WITH ANOSMIA; HH25
HP:0025132HP:0025133Abnormal serum estradiol1NF2 CL E G H47717773ORPHA:2495Meningioma220
HP:0025132HP:0025133Abnormal serum estradiol1NR0B1 CL E G H1907960ORPHA:25151046,XY partial gonadal dysgenesis48
HP:0025132HP:0025133Abnormal serum estradiol1NR5A1 CL E G H25167983ORPHA:24346,XX gonadal dysgenesis38
HP:0025132HP:0025133Abnormal serum estradiol1NR5A1 CL E G H25167983ORPHA:25151046,XY partial gonadal dysgenesis38
HP:0025132HP:0025133Abnormal serum estradiol1NUP107 CL E G H5712229914ORPHA:24346,XX gonadal dysgenesis5
HP:0025132HP:0025133Abnormal serum estradiol1PDGFB CL E G H51558800ORPHA:2495Meningioma9
HP:0025132HP:0025133Abnormal serum estradiol1PIK3CA CL E G H52908975ORPHA:2495Meningioma162
HP:0025132HP:0025133Abnormal serum estradiol1POLR3A CL E G H1112830074ORPHA:3455Wiedemann-Rautenstrauch syndrome138
HP:0025132HP:0025133Abnormal serum estradiol1POLR3H CL E G H17156830349ORPHA:24346,XX gonadal dysgenesis
HP:0025132HP:0025133Abnormal serum estradiol1POR CL E G H54479208ORPHA:95699Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency76
HP:0025132HP:0025133Abnormal serum estradiol1PRKAR1A CL E G H55739388ORPHA:1501Adrenocortical carcinoma134
HP:0025132HP:0025133Abnormal serum estradiol1PSMC3IP CL E G H2989317928ORPHA:24346,XX gonadal dysgenesis2
HP:0025132HP:0025133Abnormal serum estradiol1SEMA3A CL E G H1037110723OMIM:614897Hypogonadotropic hypogonadism 16 with or without anosmia14
HP:0025132HP:0025133Abnormal serum estradiol1SMARCB1 CL E G H659811103ORPHA:2495Meningioma87
HP:0025132HP:0025133Abnormal serum estradiol1SMARCE1 CL E G H660511109ORPHA:2495Meningioma47
HP:0025132HP:0025133Abnormal serum estradiol1SMO CL E G H660811119ORPHA:2495Meningioma22
HP:0025132HP:0025133Abnormal serum estradiol1SOX9 CL E G H666211204ORPHA:25151046,XY partial gonadal dysgenesis109
HP:0025132HP:0025133Abnormal serum estradiol1SPIDR CL E G H2351428971ORPHA:24346,XX gonadal dysgenesis2
HP:0025132HP:0025133Abnormal serum estradiol1SPIDR CL E G H2351428971OMIM:619665OVARIAN DYSGENESIS 9; ODG92
HP:0025132HP:0025133Abnormal serum estradiol1SRY CL E G H673611311ORPHA:25151046,XY partial gonadal dysgenesis23
HP:0025132HP:0025133Abnormal serum estradiol1STAG3 CL E G H1073411356OMIM:615723Premature ovarian failure 84
HP:0025132HP:0025133Abnormal serum estradiol1SUFU CL E G H5168416466ORPHA:2495Meningioma124
HP:0025132HP:0025133Abnormal serum estradiol1TERT CL E G H701511730ORPHA:1501Adrenocortical carcinoma238
HP:0025132HP:0025133Abnormal serum estradiol1TERT CL E G H701511730ORPHA:2495Meningioma238
HP:0025132HP:0025133Abnormal serum estradiol1TP53 CL E G H715711998ORPHA:1501Adrenocortical carcinoma911
HP:0025132HP:0025133Abnormal serum estradiol1TRAF7 CL E G H8423120456ORPHA:2495Meningioma
HP:0025132HP:0025133Abnormal serum estradiol1VAMP7 CL E G H684511486ORPHA:25151046,XY partial gonadal dysgenesis2
HP:0025132HP:0025133Abnormal serum estradiol1WT1 CL E G H749012796ORPHA:25151046,XY partial gonadal dysgenesis177
HP:0025132HP:0025133Abnormal serum estradiol1WT1 CL E G H749012796ORPHA:347Frasier syndrome177
HP:0025132HP:0025133Abnormal serum estradiol1WWOX CL E G H5174112799ORPHA:25151046,XY partial gonadal dysgenesis149
HP:0025132HP:0025133Abnormal serum estradiol1XRCC2 CL E G H751612829OMIM:619146PREMATURE OVARIAN FAILURE 17; POF17125
HP:0025132HP:0025133Abnormal serum estradiol1ZFPM2 CL E G H2341416700ORPHA:25151046,XY partial gonadal dysgenesis31
HP:0025132HP:0025133Abnormal serum estradiol1ZNRF3 CL E G H8413318126ORPHA:1501Adrenocortical carcinoma
HP:0025132HP:0025133Abnormal serum estradiol1ZSWIM7 CL E G H12515026993ORPHA:24346,XX gonadal dysgenesis
HP:0025132HP:0025133Abnormal serum estradiol1ZSWIM7 CL E G H12515026993OMIM:619834OVARIAN DYSGENESIS 10; ODG10
HP:0025132HP:0025139Increased serum estrone2 CL E G H
HP:0025132HP:0025137Decreased serum estriol2 CL E G H
HP:0025132HP:0025136Increased serum estriol2 CL E G H
HP:0025132HP:0025140Decreased serum estrone2 CL E G H
HP:0025132HP:0008214Decreased serum estradiol2AKT1 CL E G H207391ORPHA:2495MeningiomaHP:0040282 - Frequent54
HP:0025132HP:0025134Increased serum estradiol2AR CL E G H367644ORPHA:99429Complete androgen insensitivity syndromeHP:0040281 - Very frequent125
HP:0025132HP:0025134Increased serum estradiol2AR CL E G H367644ORPHA:90797Partial androgen insensitivity syndromeHP:0040283 - Occasional125
HP:0025132HP:0008214Decreased serum estradiol2BAP1 CL E G H8314950ORPHA:2495MeningiomaHP:0040282 - Frequent184
HP:0025132HP:0008214Decreased serum estradiol2BMP15 CL E G H92101068ORPHA:24346,XX gonadal dysgenesisHP:0040281 - Very frequent16
HP:0025132HP:0008214Decreased serum estradiol2BNC1 CL E G H6461081ORPHA:24346,XX gonadal dysgenesisHP:0040281 - Very frequent
HP:0025132HP:0008214Decreased serum estradiol2BNC1 CL E G H6461081OMIM:618723PREMATURE OVARIAN FAILURE 16; POF16
HP:0025132HP:0025134Increased serum estradiol2CDKN2A CL E G H10291787ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent289
HP:0025132HP:0008214Decreased serum estradiol2CTDP1 CL E G H91502498OMIM:604168Congenital cataracts, facial dysmorphism, and neuropathy.17
HP:0025132HP:0025134Increased serum estradiol2CTNNB1 CL E G H14992514ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent88
HP:0025132HP:0008214Decreased serum estradiol2CYB5A CL E G H15282570ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiencyHP:0040281 - Very frequent2
HP:0025132HP:0008214Decreased serum estradiol2CYP17A1 CL E G H15862593ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiencyHP:0040281 - Very frequent53
HP:0025132HP:0008214Decreased serum estradiol2DCAF17 CL E G H8006725784ORPHA:3464Woodhouse-Sakati syndromeHP:0040281 - Very frequent87
HP:0025132HP:0008214Decreased serum estradiol2DHH CL E G H508462865ORPHA:16856346,XY gonadal dysgenesis-motor and sensory neuropathy syndromeHP:0040281 - Very frequent21
HP:0025132HP:0008214Decreased serum estradiol2DHX37 CL E G H5764717210ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent2
HP:0025132HP:0008214Decreased serum estradiol2DMRT3 CL E G H5852413909ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent1
HP:0025132HP:0008214Decreased serum estradiol2FOXL2 CL E G H6681092ORPHA:572333Blepharophimosis-ptosis-epicanthus inversus syndrome plusHP:0040283 - Occasional92
HP:0025132HP:0008214Decreased serum estradiol2FSHB CL E G H24883964ORPHA:52901Isolated follicle stimulating hormone deficiencyHP:0040281 - Very frequent23
HP:0025132HP:0008214Decreased serum estradiol2FSHR CL E G H24923969ORPHA:24346,XX gonadal dysgenesisHP:0040281 - Very frequent50
HP:0025132HP:0008214Decreased serum estradiol2GATA4 CL E G H26264173ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent87
HP:0025132HP:0008214Decreased serum estradiol2GNRH1 CL E G H27964419OMIM:614841Hypogonadotropic hypogonadism 12 with or without anosmia.15
HP:0025132HP:0008214Decreased serum estradiol2KISS1 CL E G H38146341OMIM:614842Hypogonadotropic hypogonadism 13 with or without anosmia3
HP:0025132HP:0008214Decreased serum estradiol2LARS2 CL E G H2339517095OMIM:615300Perrault syndrome 454
HP:0025132HP:0008214Decreased serum estradiol2LEP CL E G H39526553ORPHA:66628Obesity due to congenital leptin deficiencyHP:0040281 - Very frequent47
HP:0025132HP:0008214Decreased serum estradiol2LEPR CL E G H39536554ORPHA:179494Obesity due to leptin receptor gene deficiencyHP:0040281 - Very frequent46
HP:0025132HP:0008214Decreased serum estradiol2MAP3K1 CL E G H42146848ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent13
HP:0025132HP:0008214Decreased serum estradiol2MCM9 CL E G H25439421484OMIM:616185Ovarian dysgenesis 44
HP:0025132HP:0008214Decreased serum estradiol2MRPS22 CL E G H5694514508ORPHA:24346,XX gonadal dysgenesisHP:0040281 - Very frequent25
HP:0025132HP:0008214Decreased serum estradiol2NDNF CL E G H7962526256OMIM:618841HYPOGONADOTROPIC HYPOGONADISM 25 WITH ANOSMIA; HH25
HP:0025132HP:0008214Decreased serum estradiol2NF2 CL E G H47717773ORPHA:2495MeningiomaHP:0040282 - Frequent220
HP:0025132HP:0008214Decreased serum estradiol2NR0B1 CL E G H1907960ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent48
HP:0025132HP:0008214Decreased serum estradiol2NR5A1 CL E G H25167983ORPHA:24346,XX gonadal dysgenesisHP:0040281 - Very frequent38
HP:0025132HP:0008214Decreased serum estradiol2NR5A1 CL E G H25167983ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent38
HP:0025132HP:0008214Decreased serum estradiol2NUP107 CL E G H5712229914ORPHA:24346,XX gonadal dysgenesisHP:0040281 - Very frequent5
HP:0025132HP:0008214Decreased serum estradiol2PDGFB CL E G H51558800ORPHA:2495MeningiomaHP:0040282 - Frequent9
HP:0025132HP:0008214Decreased serum estradiol2PIK3CA CL E G H52908975ORPHA:2495MeningiomaHP:0040282 - Frequent162
HP:0025132HP:0025134Increased serum estradiol2POLR3A CL E G H1112830074ORPHA:3455Wiedemann-Rautenstrauch syndromeHP:0040284 - Very rare138
HP:0025132HP:0008214Decreased serum estradiol2POLR3H CL E G H17156830349ORPHA:24346,XX gonadal dysgenesisHP:0040281 - Very frequent
HP:0025132HP:0008214Decreased serum estradiol2POR CL E G H54479208ORPHA:95699Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiencyHP:0040282 - Frequent76
HP:0025132HP:0025134Increased serum estradiol2PRKAR1A CL E G H55739388ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent134
HP:0025132HP:0008214Decreased serum estradiol2PSMC3IP CL E G H2989317928ORPHA:24346,XX gonadal dysgenesisHP:0040281 - Very frequent2
HP:0025132HP:0008214Decreased serum estradiol2SEMA3A CL E G H1037110723OMIM:614897Hypogonadotropic hypogonadism 16 with or without anosmia14
HP:0025132HP:0008214Decreased serum estradiol2SMARCB1 CL E G H659811103ORPHA:2495MeningiomaHP:0040282 - Frequent87
HP:0025132HP:0008214Decreased serum estradiol2SMARCE1 CL E G H660511109ORPHA:2495MeningiomaHP:0040282 - Frequent47
HP:0025132HP:0008214Decreased serum estradiol2SMO CL E G H660811119ORPHA:2495MeningiomaHP:0040282 - Frequent22
HP:0025132HP:0008214Decreased serum estradiol2SOX9 CL E G H666211204ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent109
HP:0025132HP:0008214Decreased serum estradiol2SPIDR CL E G H2351428971ORPHA:24346,XX gonadal dysgenesisHP:0040281 - Very frequent2
HP:0025132HP:0008214Decreased serum estradiol2SPIDR CL E G H2351428971OMIM:619665OVARIAN DYSGENESIS 9; ODG92
HP:0025132HP:0008214Decreased serum estradiol2SRY CL E G H673611311ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent23
HP:0025132HP:0008214Decreased serum estradiol2STAG3 CL E G H1073411356OMIM:615723Premature ovarian failure 84
HP:0025132HP:0008214Decreased serum estradiol2SUFU CL E G H5168416466ORPHA:2495MeningiomaHP:0040282 - Frequent124
HP:0025132HP:0025134Increased serum estradiol2TERT CL E G H701511730ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent238
HP:0025132HP:0008214Decreased serum estradiol2TERT CL E G H701511730ORPHA:2495MeningiomaHP:0040282 - Frequent238
HP:0025132HP:0025134Increased serum estradiol2TP53 CL E G H715711998ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent911
HP:0025132HP:0008214Decreased serum estradiol2TRAF7 CL E G H8423120456ORPHA:2495MeningiomaHP:0040282 - Frequent
HP:0025132HP:0008214Decreased serum estradiol2VAMP7 CL E G H684511486ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent2
HP:0025132HP:0008214Decreased serum estradiol2WT1 CL E G H749012796ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent177
HP:0025132HP:0008214Decreased serum estradiol2WT1 CL E G H749012796ORPHA:347Frasier syndromeHP:0040281 - Very frequent177
HP:0025132HP:0008214Decreased serum estradiol2WWOX CL E G H5174112799ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent149
HP:0025132HP:0008214Decreased serum estradiol2XRCC2 CL E G H751612829OMIM:619146PREMATURE OVARIAN FAILURE 17; POF17125
HP:0025132HP:0008214Decreased serum estradiol2ZFPM2 CL E G H2341416700ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent31
HP:0025132HP:0025134Increased serum estradiol2ZNRF3 CL E G H8413318126ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent
HP:0025132HP:0008214Decreased serum estradiol2ZSWIM7 CL E G H12515026993ORPHA:24346,XX gonadal dysgenesisHP:0040281 - Very frequent
HP:0025132HP:0008214Decreased serum estradiol2ZSWIM7 CL E G H12515026993OMIM:619834OVARIAN DYSGENESIS 10; ODG10


Genes (57) :AKT1 AR BAP1 BMP15 BNC1 CDKN2A CTDP1 CTNNB1 CYB5A CYP17A1 DCAF17 DHH DHX37 DMRT3 FOXL2 FSHB FSHR GATA4 GNRH1 KISS1 LARS2 LEP LEPR MAP3K1 MCM9 MRPS22 NDNF NF2 NR0B1 NR5A1 NUP107 PDGFB PIK3CA POLR3A POLR3H POR PRKAR1A PSMC3IP SEMA3A SMARCB1 SMARCE1 SMO SOX9 SPIDR SRY STAG3 SUFU TERT TP53 TRAF7 VAMP7 WT1 WWOX XRCC2 ZFPM2 ZNRF3 ZSWIM7

Diseases (28) :ORPHA:2495 ORPHA:99429 ORPHA:90797 ORPHA:243 OMIM:618723 ORPHA:1501 OMIM:604168 ORPHA:90796 ORPHA:3464 ORPHA:168563 ORPHA:251510 ORPHA:572333 ORPHA:52901 OMIM:614841 OMIM:614842 OMIM:615300 ORPHA:66628 ORPHA:179494 OMIM:616185 OMIM:618841 ORPHA:3455 ORPHA:95699 OMIM:614897 OMIM:619665 OMIM:615723 ORPHA:347 OMIM:619146 OMIM:619834
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.